Howard Capital Management Inc.

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1733173 ROSWELL, GA

Position in ALNY

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,136,689

+$617,224 QoQ

Shares Held

3,776

+140.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#383

of 784 holders

Holding Since

Sep 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Howard Capital Management Inc. holds $7,085,291 across 3 Biotechnology names. ALNY ranks #3 (16.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,113	$4,029,970
2	REGN	Regeneron Pharmaceuticals, Inc.	3,077	$1,918,632
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	3,776	$1,136,689

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,136,689	3,776	+140.5%	Shares	Sole	2026-07-28
2026-03-31	$519,465	1,570	-57.3%	Shares	Sole	2026-05-05
2025-12-31	$1,463,352	3,680	+330.9%	Shares	Sole	2026-01-23
2025-09-30	$389,424	854	+2.9%	Shares	Sole	2025-11-04
2025-06-30	$270,654	830	+9.8%	Shares	Sole	2025-08-01
2024-09-30	$207,922	756	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.